RESUMO
Aims@#The present study determined Candida species occurrence in the mouth of HIV/AIDS, pregnant women and healthy individuals, and Candida susceptibility to antimycotics.@*Methodology and results@#A cross-sectional study of the Candida species occurrence and their in vitro sensitivity to nystatin, clotrimazole, ketoconazole and fluconazole was studied. Oral swabs were taken from the dorsum of the tongue of 63 HIV/AIDS patients, 38 pregnant women and 53 apparently healthy humans served as control. All participants gave their consent. The samples were cultured for isolation of Candida species. The susceptibility of commonly used antimycotics against Candida species was determined using agar-well and disc-diffusion methods. The broth dilution method was adopted in the determination of the minimum inhibitory concentration of the drugs. The rate of Candida species colonization in HIV/AIDS patients was higher than that among pregnant women and apparently healthy humans. Candida albicans had the highest frequency. Candida species displayed higher sensitivity to nystatin and clotrimazole than ketoconazole and fluconazole. Candida albicans exhibiting low sensitivity to fluconazole were found in the mouth of AIDS patients, pregnant women and apparently healthy humans.@*Conclusion, significance and impact of study@#Candida species prevalence was highest among HIV patients. Candida albicans had the highest frequency among the study groups and had reduced susceptibility to fluconazole. The findings of the study underscore the need for regular surveillance and susceptibility testing of Candida isolates before prescription of antimycotics, especially in cases of chronic infection, as well as the development of safe and efficacious treatment alternatives since Candida isolates are becoming less susceptible to fluconazole.
Assuntos
Candidíase , Doenças da Boca , HIV , GestantesRESUMO
Objective Studies are rarely reported on the correlation of the Toll-like receptor (TLR) gene polymorphisms with fungal infection in the Chinese Han population. This study aims to explore the association between TLR gene polymorphisms and pulmonary candida infection (PCI) and candida colonization (CC) in patients with chronic obstructive pulmonary disease (COPD) in the Guizhou Han population. Methods Using the polymerase chain reaction-direct sequencing (PCR-SBT) method, we genotyped six single nucleotide polymorphisms (SNP) of the TLR1, TLR2 and TLR4 genes in 344 Guizhou Han patients with COPD, including 80 cases complicated by PCI (the PCI group), 103 cases complicated by CC (the CC group), and 161 negative controls. We analyzed the correlation of the SNPs with PCI and CC in the COPD patients in different genetic models with the SNPstats online software, measured the levels of IL-6, IL-8, IL-1β and TNF-α proteins in the plasma of the patients by ELISA, and assessed the functional consequences of these polymorphisms. Results The polymorphisms of rs5743611, rs5743708, rs4986790 and rs4986791 were found in none of the patients. The genotype frequency of rs4833095 was significantly different between the PCI and control groups in the codominant, dominant and overdominant models (P < 0.05), with the dominant model as the best genetic pattern. No statistically significant difference was observed either in the rs4833095 genotype frequency between the CC and control groups (P > 0.05) or in the rs5743618 genotype frequency between any two groups (P > 0.05). In the PCI group, the T allele of the rs4833095 polymorphism significantly decreased the levels of IL-6, IL-8 and IL-1β in the plasma (P < 0.05), and that of TNF-α as well, though with no statistically significant difference (P > 0.05). Conclusion The rs4833095 polymorphism of the TLR1 gene is associated with PCI in COPD patients. The T allele of rs4833095 may affect the function of TLR1, decrease the levels of IL-6, IL-8 and IL-1β proteins in the plasma. Neither rs4833095 nor rs5743618 gene polymorphism is correlated with the susceptibility to candida colonization.
RESUMO
Background & objectives: The changing spectrum of Candida species in causation of oropharyngeal candidiasis and their antifungal susceptibility pattern among the HIV infected individuals has made the identification to species level mandatory and detection of drug resistance necessary for patient care. The present study was carried out to determine the species distribution and antifungal susceptibility profile of oral Candida isolates colonizing or infecting both HIV seropositive and seronegative individuals. Methods: A case-control study was conducted including 141 consecutive, non-repeat HIV-seropositive individuals and an equal number of sex and age matched HIV-seronegative control. Speciation of the oropharyngeal Candida isolates was done using standard yeast identification protocol. Antifungal susceptibility testing was done by the disk-diffusion method as well as by Fungitest method. Results: From the 59 culture positive HIV seropositive cases, 61 Candida isolates were recovered; Candida albicans (n=47, 77.0%), C. dubliniensis (n=9, 14.7%), C. parapsilosis (n=2, 3.2%), C. glabrata (n=2, 3.2%), and C. famata (n=1, 1.6%). Candida colonization in HIV-seropositive individuals was significantly higher than that of HIV-seronegative (control) group. Antifungal susceptibility testing revealed (n=6, 9.3%) C. albicans isolates resistant to voriconazole and fluconazole by disk-diffusion method whereas no resistance was seen by Fungitest method. Interpretation & conclusions: C. albicans was the commonest Candida species infecting or colonizing HIV seropositive individuals. Oropharyngeal Candida isolates had high level susceptibility to all the major antifungals commonly in use. Increased level of immunosuppression in HIV-seropositives and drug resistance of non-albicans Candida species makes identification and susceptibility testing of Candida species necessary in different geographical areas of the country.